Healthcare &
Life Sciences

Health is not a cost. It is a system of access, innovation, and value.

Care is universal. Delivery is engineered.

We advise hospitals, pharma, medtech, and investors with clinical, regulatory, and financial rigor — from Paris to Patna.

Healthcare Value Chain Decision Matrix

05

Strategic Access & Ecosystem

PM-JAY, digital health, and public-private partnerships.

04

Capital & Cost Efficiency

Capex optimization, working capital, and outcome-based funding.

03

Clinical & Regulatory Pathway

CDSCO approvals, clinical trials, and bioequivalence strategy.

02

Pricing & Reimbursement

DPCO, NPPA, and value-based pricing frameworks.

01

Operational Delivery & Quality

Lean hospital ops, digital patient journey, and NABH compliance.

Core Consulting Capabilities

Business Transformation & Access Strategy

Affordable access, digital health, and hospital operating model optimization.

  • Ayushman Bharat PM-JAY empanelment strategy
  • Digital health stack (UHI, ABDM, e-Sanjeevani)
  • Hospital revenue cycle & cost-to-serve reduction
  • Pharma pricing under DPCO & NPPA compliance
  • Value-based care & outcome-linked reimbursement
  • High-performance healthcare delivery design

Turnaround & Restructuring Advisory

Cash preservation, creditor negotiations, and value recovery in healthcare distress.

  • 13-week cash flow & working capital bridge
  • Medical equipment lease restructuring
  • Pharma API & formulation inventory optimization
  • DIP financing & pre-packaged IBC resolution
  • Creditor committee & lender advisory
  • Operational stabilization & capex deferral

Strategic Communications & Regulatory Advocacy

Reputation management, CDSCO compliance, and policy engagement.

  • Crisis response (drug recall, clinical trial issues)
  • Investor perception audits & equity story
  • CDSCO, NPPA, ICMR consultation responses
  • FDI 100% auto route & Press Note 3 compliance
  • KOL engagement & medical affairs strategy
  • Internal change & culture transformation

Clinical & Regulatory Diligence

CDSCO approval pathways, bioequivalence, and clinical trial valuation.

  • CDSCO CTD dossier review & gap analysis
  • Bioequivalence (BE) study design & CRO selection
  • Clinical trial phase valuation & NPV modeling
  • Patent cliff & Paragraph IV strategy
  • License-in & co-development term sheet
  • Data room & regulatory due diligence

Transactions & Valuation

Commercial, operational, and financial diligence for pharma, medtech, and hospital M&A.

  • Buy-side & sell-side due diligence
  • Quality of earnings & pipeline NPV
  • Hospital EBITDA & bed-level P&L
  • Synergy modeling & integration planning
  • SPA risk review (MAC, regulatory approvals)
  • FDI & CCI clearance strategy

The future of health is not treatment. It is access.

We design the strategy, execution, and credibility to deliver it.

Begin Healthcare Mandate